Background
==========

The most important factor for late implant failure in total hip arthroplasty is aseptic mechanical loosening of one or both components. The Nordic arthroplasty registries (Sweden, Norway and Denmark) show aseptic loosening as the main reason for revision in total hip arthroplasty (34.8-50.4%), followed by dislocation (23.4-33.5%) and infection (15.0-15.8%) \[[@B1]\]. Periprosthetic bone resorption, due to a cellular- and molecular-mediated foreign body reaction to polyethylene wear particles, is one of the main causes for this loosening \[[@B2],[@B3]\].

In the 1950s and 1960s, total hip arthroplasty was performed using a metal-on-metal articulation \[[@B4],[@B5]\]. In the 1970s, due to the success of Charnley's low friction arthroplasty \[[@B6]\], metal-on-polyethylene articulations were increasingly applied. As polyethylene wear particles turned out to promote aseptic loosening, newer polyethylenes were developed to reduce wear. In the 1990s first-generation cross-linked ultra high molecular weight polyethylenes were introduced. This development led to a reduction in polyethylene wear. In looking for alternative bearing couples lacking the issue of polyethylene wear, the use of hard-on-hard bearings like metal-on-metal and ceramic-on-ceramic increased, especially in young active patients \[[@B7]\].

Hard-on-hard bearings also have shown disadvantages though. Although rare, ceramic articulations might lead to fracture of the ceramic bearing and produce squeaking noises \[[@B8]\]. Concerns remain over metal-on-metal articulations because of the metal ion release and subsequent elevated serum metal ion concentration \[[@B9]\]. Moreover, unpredictable local tissue reaction on metal particles can result in pseudo-tumor formation around the hip joint and perivascular lymphocytic infiltration because of a delayed-type hypersensitivity reaction (aseptic lymphocytic vasculitis associated lesion, ALVAL) \[[@B10]\]. A metal-on-polyethylene articulation seems therefore to be advocated above metal--on-metal articulation in total hip arthroplasty \[[@B11]\].

Wear characteristics of ultra-high molecular-weight polyethylene have been improved by the cross-linking technique \[[@B12],[@B13]\]. A disadvantage is the increased oxidation and decreased fatigue strength of the polyethylene due to the irradiation, remelting and annealing process used in this technique. To prevent oxidation and increase mechanical strength, second-generation highly cross-linked polyethylene has been developed by incorporating vitamin E \[[@B14],[@B15]\]. *In vitro* testing of these vitamin-E stabilized polyethylene cups shows good wear properties and improved mechanical and fatigue properties \[[@B16]\]. The influence of vitamin E-stabilized polyethylene cups on acetabular bone mineral density (BMD) is unknown. Hypothetically, this modified polyethylene leads to changes in acetabular bone mineral density due to its different mechanical properties.

The objective of this study is to compare vitamin E-stabilized highly cross-linked polyethylene with conventional cross-linked polyethylene in "reversed hybrid" total hip arthroplasties (cemented all-polyethylene cups combined with uncemented femoral stems). We hypothesize that the adjunction of vitamin E to polyethylene leads to a decrease in polyethylene wear in the long-term (primary outcome parameter). We also expect changes in BMD, less osteolysis, equal functional scores and increased implant survival in polyethylene incorporated with vitamin E (secondary outcome parameters) in the long term. The present paper reports on the design of the study.

Methods
=======

Design
------

A randomized controlled trial will be conducted. Patients are randomized into one of the two treatment groups using concealed envelopes. Cluster randomization (per 10 patients) will be applied and the random allocator sequence will be computer-generated by an independent planner. Envelopes are opened one week before surgery. Patients are blinded for treatment. Only the surgeon and the primary investigator are aware of the allocation type. Follow-up is therefore done by an independent investigator, who is blinded for the treatment allocation. The study design, procedures and informed consent are approved by the local Medical Ethical Committee (registration number 2011-29). The trial is registered in the Netherlands Trial Registry (NTR3049). Guidelines of the Consort Statement are followed \[[@B17]\].

Study population
----------------

The study will be conducted at the Department of Orthopaedic Surgery of the Martini Hospital, Groningen, the Netherlands. Patients to be included suffer from non-inflammatory degenerative joint disease of the hip and are scheduled for a primary unilateral total hip arthroplasty, and are aged under 70 years. Exclusion criteria are secondary osteoarthritis of the hip, (active) arthritis (e.g. rheumatic disease), peripheral neuropathy, history of CVA or cognitive impairment (e.g. dementia). Participation in the study is voluntary and informed consent is required. The inclusion period is planned from January 2012 to January 2014.

Intervention
------------

Both investigated groups will receive a reversed hybrid total hip arthroplasty. Gentamycine cement (Palacos®R + G, Heraeus) will be used for cup fixation, applying third-generation cementing techniques including vacuum mixing, pulsed lavage and pressurization. The same cementless 28-mm femoral component is used in both groups: a proximally plasma-sprayed porous coated titanium alloy (Ti6Al4V) stem (Mallory-Head®, Biomet) with a cobalt-chromium-molybdenum 28 mm femoral head.

One group will receive a cemented vitamin E-stabilized highly cross-linked polyethylene acetabular component (E1™ Muller cup, Exceed ABT Cemented Cup System, Biomet). The other group will receive a cemented conventional cross-linked polyethylene acetabular component without the adjunction of vitamin E (ArCom™ Muller cup, Exceed ABT Cemented Cup System, Biomet).

A posterolateral surgical approach in lateral decubitus position is used. Antibiotic prophylaxis with first-generation cephalosporin will be given preoperatively and during the first 24 hours intravenously.

Follow-up
---------

In this study the main outcome parameter is polyethylene wear (mm/y) 10 years postoperatively. Secondary outcome parameters are periacetabular bone mineral density, periprosthetic osteolysis, patient- and physician-reported outcome and implant survival (Table [1](#T1){ref-type="table"}). Depending on the outcome parameters, measurements will take place preoperatively, 6 weeks, and 1, 3, 5, 7 and 10 years postoperatively.

###### 

Secondary outcome parameters

         
  ----- -----------------------------------------------------------------------------------------------------------------
  1\.   polyethylene wear at 1, 3, 5 and 7 years postoperatively
  2\.   relative decrease/increase in acetabular bone mineral density (BMD) at 1 and 2 years postoperatively
  3\.   acetabular and proximal femoral osteolytic changes at 1, 3, 5, 7 and 10 years postoperatively
  4\.   patient-reported functional outcome (HOOS and SQUASH) at 6 weeks and at 1, 3, 5, 7 and 10 years postoperatively
  5\.   physician-reported functional outcome (Harris Hip Score) at 6 weeks and at 1, 3, 5 and 10 years postoperatively
  6\.   survival (number of revisions) determined at 5 and 10 years postoperatively

Other study parameters: gender, age, *BMI*, severity of arthrosis, complications, size and inclination of the cup, surgical time and intraoperative blood loss.

### Wear and osteolysis assessment

Wear will be determined on the routinely made conventional AP radiographs. Standard supine anteroposterior (AP) pelvic hip radiographs (with 115% magnification) will be taken. The X-rays at 6 weeks will serve as baseline, and will be compared 1, 3, 5, 7 and 10 years postoperatively. Wear will be assessed using the 2D measurement method as described by The et al. \[[@B18]\]. This method has been clinical validated by RSA and corrects for projection differences of the acetabular component. It has the advantage of approximating 3D-wear measurements without the need of lateral radiographs. Periacetabular and femoral radiolucencies will be assessed according to the three zones of De Lee and Charnley \[[@B19]\] and the femoral zones (especially zone 7) of Gruen et al. \[[@B20]\]. The scoring will be undertaken by an independent reviewer.

### Bone densitometry

BMD measurements will be performed using a dual energy X-ray absorptiometry (DEXA) scanner (Hologic Inc., Bedford, Mass., USA) in order to calculate BMD changes in the pelvis as suggested by Wilkinson \[[@B21]\]. The contralateral normal hip will be scanned following a standard manufacturer\'s protocol to establish BMD in the femoral neck, trochanter, intertrochanteric, total hip and Ward\'s triangle sites.

### Functional outcome

The Hip disability and Osteoarthritis Outcome Score (HOOS) will be used to assess patient-reported functional status, health-related quality of life and physical activity \[[@B22],[@B23]\]. The short questionnaire to assess health-enhancing physical activity (SQUASH) will be used to determine habitual physical activity behavior \[[@B24]\]. Dutch versions of the HOOS and SQUASH will be used, as they are reliable and validated questionnaires for the Dutch THA population \[[@B25],[@B26]\]. The Harris Hip Score will be used to assess physician-reported functional status, including range of motion \[[@B27],[@B28]\].

Sample size
-----------

It is our hypothesis that reversed hybrid total hip arthroplasties with vitamin E-stabilized polyethylene will show less polyethylene wear at 10 years compared to reversed hybrid total hip arthroplasty without the adjunction of vitamin E. In order to detect at least a clinically relevant difference in wear of 0.5 mm with a standard deviation of 0.07 mm, 63 patients are needed in each group (alpha 0.05, power 0.80). Based on previous studies we expect a drop-out rate of 15%. We therefore aim to include 75 patients in each group, thus 150 patients in total.

Statistical analysis
--------------------

### Descriptive statistics

Descriptive statistics (means and standard deviations) will be used to describe the patient characteristics and outcome variables at the measurement points.

### Univariate analysis

Student's *T*-test will be used to determine if there is a difference in wear at 10 years postoperatively between the two groups. Differences in other outcome measures (osteolytic changes, bone mineral density, HOOS, Harris Hip score, SQUASH) between the two groups will also be analyzed with a student's *T*-test (or non-parametric equivalent in case of a skewed distribution) at different measurement points.

### Multivariate analysis

A GEE (Generalized Estimating Equation) analysis will be used to determine whether there is a difference on the primary and secondary outcome variables between the two groups over time, adjusted for relevant covariates. A p-value of \< 0.05 is considered statistically significant.

Discussion
==========

As previously mentioned, *in vitro* results of vitamin E-incorporated polyethylene cups are promising, showing increased wear resistance and improved mechanical and fatigue properties. However, as yet no randomized controlled clinical data have been published on the mid- and long-term outcome of these modified polyethylene cups. This study primarily focuses on the outcome of wear in the long-term (10 years), comparing vitamin E-incorporated polyethylene with conventional polyethylene in reversed hybrid total hip arthroplasties. Short- and mid-term data will also be investigated in terms of periacetabular bone density and functional outcome.

To our knowledge, there are no randomized controlled trials that evaluate the incorporation of vitamin E in cemented polyethylene cups versus cemented polyethylene cups without the adjunction of vitamin E in total hip arthroplasty.

Conclusion
==========

This randomized controlled trial has been designed to determine wear, bone mineral density, functional outcome and survival in reversed hybrid total hip arthroplasty with vitamin E-stabilized highly cross-linked polyethylene versus reversed hybrid total hip arthroplasty with conventional cross-linked polyethylene.
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